APO Research

APO RESEARCH · REPORT

Major Histocompatibility Complex

Selected research

Industry Growth & Trends

Global Major Histocompatibility Complex Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Major Histocompatibility Complex market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Major Histocompatibility Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Major Histocompatibility Complex market include Santa Cruz Biotechnology, ProImmune, Novus Biologicals, Miltenyi Biotec, Creative BioMart and Abbexa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Major Histocompatibility Complex market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Major Histocompatibility Complex market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Major Histocompatibility Complex market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Major Histocompatibility Complex.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Major Histocompatibility Complex market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Major Histocompatibility Complex Market by Company

Santa Cruz Biotechnology

ProImmune

Novus Biologicals

Miltenyi Biotec

Creative BioMart

Abbexa

Major Histocompatibility Complex Segment by Type

MHC Class II

MHC Class III

MHC Class I

Major Histocompatibility Complex Segment by Application

Medical Care

Research

Other

Major Histocompatibility Complex Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Major Histocompatibility Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Major Histocompatibility Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Major Histocompatibility Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Major Histocompatibility Complex companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Major Histocompatibility Complex Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Major Histocompatibility Complex Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Major Histocompatibility Complex Market Share by Region (2021-2026) Table 4. Global Major Histocompatibility Complex Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Major Histocompatibility Complex Market Share by Region (2027-2032) Table 6. Global Major Histocompatibility Complex Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Major Histocompatibility Complex Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Major Histocompatibility Complex Market Size Share by Type (2021-2026) Table 9. Global Major Histocompatibility Complex Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Major Histocompatibility Complex Market Size Share Forecasted by Type (2027-2032) Table 11. North America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Major Histocompatibility Complex Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Major Histocompatibility Complex Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Major Histocompatibility Complex Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Major Histocompatibility Complex Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Major Histocompatibility Complex Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Major Histocompatibility Complex Market Size Share by Application (2021-2026) Table 24. Global Major Histocompatibility Complex Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Major Histocompatibility Complex Market Size Share Forecasted by Application (2027-2032) Table 26. North America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Major Histocompatibility Complex Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Major Histocompatibility Complex Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Major Histocompatibility Complex Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Major Histocompatibility Complex Industry Trends Table 37. Major Histocompatibility Complex Industry Drivers Table 38. Major Histocompatibility Complex Industry Opportunities and Challenges Table 39. Major Histocompatibility Complex Industry Restraints Table 40. Global Major Histocompatibility Complex Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Major Histocompatibility Complex Revenue Market Share by Company (2021-2026) Table 42. Global Major Histocompatibility Complex Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Major Histocompatibility Complex Key Company Headquarters & Area Served Table 44. Global Major Histocompatibility Complex Company, Product Type & Application Table 45. Global Major Histocompatibility Complex Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Major Histocompatibility Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Santa Cruz Biotechnology Company Information Table 49. Santa Cruz Biotechnology Business Overview Table 50. Santa Cruz Biotechnology Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio Table 52. Santa Cruz Biotechnology Recent Development Table 53. ProImmune Company Information Table 54. ProImmune Business Overview Table 55. ProImmune Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ProImmune Major Histocompatibility Complex Product Portfolio Table 57. ProImmune Recent Development Table 58. Novus Biologicals Company Information Table 59. Novus Biologicals Business Overview Table 60. Novus Biologicals Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novus Biologicals Major Histocompatibility Complex Product Portfolio Table 62. Novus Biologicals Recent Development Table 63. Miltenyi Biotec Company Information Table 64. Miltenyi Biotec Business Overview Table 65. Miltenyi Biotec Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Miltenyi Biotec Major Histocompatibility Complex Product Portfolio Table 67. Miltenyi Biotec Recent Development Table 68. Creative BioMart Company Information Table 69. Creative BioMart Business Overview Table 70. Creative BioMart Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Creative BioMart Major Histocompatibility Complex Product Portfolio Table 72. Creative BioMart Recent Development Table 73. Abbexa Company Information Table 74. Abbexa Business Overview Table 75. Abbexa Major Histocompatibility Complex Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Abbexa Major Histocompatibility Complex Product Portfolio Table 77. Abbexa Recent Development Table 78. North America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Major Histocompatibility Complex Market Share by Country (2021-2026) Table 81. North America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Major Histocompatibility Complex Market Share Forecast by Country (2027-2032) Table 83. Europe Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Major Histocompatibility Complex Market Share by Country (2021-2026) Table 86. Europe Major Histocompatibility Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Major Histocompatibility Complex Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Major Histocompatibility Complex Market Share by Country (2021-2026) Table 91. Asia-Pacific Major Histocompatibility Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Major Histocompatibility Complex Market Share Forecast by Country (2027-2032) Table 93. Latin America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Major Histocompatibility Complex Market Share by Country (2021-2026) Table 96. Latin America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Major Histocompatibility Complex Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Major Histocompatibility Complex Market Share by Country (2021-2026) Table 101. Middle East & Africa Major Histocompatibility Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Major Histocompatibility Complex Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Major Histocompatibility Complex Product Image Figure 3. Global Major Histocompatibility Complex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Major Histocompatibility Complex Market Size (2021-2032) & (US$ Million) Figure 5. Global Major Histocompatibility Complex Market Share by Region: 2025 VS 2032 Figure 6. Global Major Histocompatibility Complex Market Share by Region (2021-2032) Figure 7. North America Major Histocompatibility Complex Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Major Histocompatibility Complex Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Major Histocompatibility Complex Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. MHC Class II Image Figure 13. Global MHC Class II Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. MHC Class III Image Figure 15. Global MHC Class III Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. MHC Class I Image Figure 17. Global MHC Class I Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Major Histocompatibility Complex Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Major Histocompatibility Complex Market Share by Type 2025 VS 2032 Figure 20. North America Major Histocompatibility Complex Market Size Share by Type (2021-2032) Figure 21. Europe Major Histocompatibility Complex Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Major Histocompatibility Complex Market Size Share by Type (2021-2032) Figure 23. Latin America Major Histocompatibility Complex Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Major Histocompatibility Complex Market Size Share by Type (2021-2032) Figure 25. Medical Care Image Figure 26. Global Medical Care Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Research Image Figure 28. Global Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Major Histocompatibility Complex Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Major Histocompatibility Complex Market Share by Application 2025 VS 2032 Figure 33. North America Major Histocompatibility Complex Market Size Share by Application (2021-2032) Figure 34. Europe Major Histocompatibility Complex Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Major Histocompatibility Complex Market Size Share by Application (2021-2032) Figure 36. Latin America Major Histocompatibility Complex Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Major Histocompatibility Complex Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Major Histocompatibility Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Major Histocompatibility Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 43. Europe Major Histocompatibility Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Major Histocompatibility Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 46. Asia-Pacific Major Histocompatibility Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Major Histocompatibility Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 49. Latin America Major Histocompatibility Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Major Histocompatibility Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 52. Middle East & Africa Major Histocompatibility Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Major Histocompatibility Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Major Histocompatibility Complex Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • MHC Class II
  • MHC Class III
  • MHC Class I
Applications
  • Medical Care
  • Research
  • Other
Companies covered
  • Santa Cruz Biotechnology
  • ProImmune
  • Novus Biologicals
  • Miltenyi Biotec
  • Creative BioMart
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Major Histocompatibility Complex Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Major Histocompatibility Complex Market Size by Region (2021-2032)
  5. 1.4.1 Global Major Histocompatibility Complex Market Size by Region (2021-2026)
  6. 1.4.2 Global Major Histocompatibility Complex Market Size by Region (2027-2032)
  7. 1.5 Key Regions Major Histocompatibility Complex Market Size (2021-2032)
  8. 1.5.1 North America Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (2021-2032)
2 Major Histocompatibility Complex Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 MHC Class II
  3. 2.1.2 MHC Class III
  4. 2.1.3 MHC Class I
  5. 2.2 Global Major Histocompatibility Complex Market Size by Type
  6. 2.2.1 Global Major Histocompatibility Complex Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Major Histocompatibility Complex Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Major Histocompatibility Complex Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Major Histocompatibility Complex Market Size by Regions
  10. 2.3.1 North America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Type (2021-2026)
3 Major Histocompatibility Complex Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Care
  3. 3.1.2 Research
  4. 3.1.3 Other
  5. 3.2 Global Major Histocompatibility Complex Market Size by Application
  6. 3.2.1 Global Major Histocompatibility Complex Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Major Histocompatibility Complex Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Major Histocompatibility Complex Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Major Histocompatibility Complex Market Size by Regions
  10. 3.3.1 North America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Major Histocompatibility Complex Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Major Histocompatibility Complex Industry Trends
  2. 4.2 Major Histocompatibility Complex Industry Drivers
  3. 4.3 Major Histocompatibility Complex Industry Opportunities and Challenges
  4. 4.4 Major Histocompatibility Complex Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Major Histocompatibility Complex Revenue (2021-2026)
  2. 5.2 Global Major Histocompatibility Complex Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Major Histocompatibility Complex Key Company Headquarters & Area Served
  4. 5.4 Global Major Histocompatibility Complex Company, Product Type & Application
  5. 5.5 Global Major Histocompatibility Complex Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Major Histocompatibility Complex Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Major Histocompatibility Complex Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Major Histocompatibility Complex Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Santa Cruz Biotechnology
  2. 6.1.1 Santa Cruz Biotechnology Company Information
  3. 6.1.2 Santa Cruz Biotechnology Business Overview
  4. 6.1.3 Santa Cruz Biotechnology Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Santa Cruz Biotechnology Major Histocompatibility Complex Product Portfolio
  6. 6.1.5 Santa Cruz Biotechnology Recent Developments
  7. 6.2 ProImmune
  8. 6.2.1 ProImmune Company Information
  9. 6.2.2 ProImmune Business Overview
  10. 6.2.3 ProImmune Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ProImmune Major Histocompatibility Complex Product Portfolio
  12. 6.2.5 ProImmune Recent Developments
  13. 6.3 Novus Biologicals
  14. 6.3.1 Novus Biologicals Company Information
  15. 6.3.2 Novus Biologicals Business Overview
  16. 6.3.3 Novus Biologicals Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novus Biologicals Major Histocompatibility Complex Product Portfolio
  18. 6.3.5 Novus Biologicals Recent Developments
  19. 6.4 Miltenyi Biotec
  20. 6.4.1 Miltenyi Biotec Company Information
  21. 6.4.2 Miltenyi Biotec Business Overview
  22. 6.4.3 Miltenyi Biotec Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Miltenyi Biotec Major Histocompatibility Complex Product Portfolio
  24. 6.4.5 Miltenyi Biotec Recent Developments
  25. 6.5 Creative BioMart
  26. 6.5.1 Creative BioMart Company Information
  27. 6.5.2 Creative BioMart Business Overview
  28. 6.5.3 Creative BioMart Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Creative BioMart Major Histocompatibility Complex Product Portfolio
  30. 6.5.5 Creative BioMart Recent Developments
  31. 6.6 Abbexa
  32. 6.6.1 Abbexa Company Information
  33. 6.6.2 Abbexa Business Overview
  34. 6.6.3 Abbexa Major Histocompatibility Complex Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Abbexa Major Histocompatibility Complex Product Portfolio
  36. 6.6.5 Abbexa Recent Developments
7 North America
  1. 7.1 North America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Major Histocompatibility Complex Market Size by Country (2021-2026)
  3. 7.3 North America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Major Histocompatibility Complex Market Size by Country (2021-2026)
  3. 8.3 Europe Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Major Histocompatibility Complex Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Major Histocompatibility Complex Market Size by Country (2021-2026)
  3. 10.3 South America Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Major Histocompatibility Complex Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research